Seller record · Telehealth service

10Rx

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: The FAQ says pharmacy certificates of analysis and third-party testing are available upon request, but it does not publish a reachable certificate or lot document.

At a glance

10RxTelehealth service

7/8criteria passed

Price: Printed on its own pages before sign-up
Sells: semaglutide with B12, tirzepatide, sermorelin, and 1 more
FDA letters: None on file

Visit 10Rx See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth peptide platform advertising quarterly GLP-1 plans with clinician review, multiple named compounding pharmacies and an upfront three-month charge.

Operating entity 10Rx, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	10Rx's semaglutide injection product page; 10Rx's FAQ
S2	Prescription gating	PASS	10Rx's FAQ
S3	Pharmacy identification	PASS	10Rx's about page; 10Rx's providers page; 10Rx's FAQ
S4	Compounding disclosure	PASS	10Rx's FAQ
S5	Analytical documentation	FAIL	10Rx's FAQ
S6	Business address	PASS	10Rx's terms and conditions
S7	Price disclosure	PASS	10Rx's semaglutide injection product page; 10Rx's tirzepatide injection product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews health history and goals, and the FAQ says a licensed physician must prescribe each product after the questionnaire.Source: 10Rx's semaglutide injection product page; 10Rx's FAQ.

S2PASSThe FAQ describes filling out a health questionnaire and then communicating with a licensed physician who must prescribe the products.Source: 10Rx's FAQ.

S3PASSThe site names Optimal Balance Pharmacy in Houston, Hallandale Pharmacy in Florida and VialsRx as prescription fulfillment partners.Source: 10Rx's about page; 10Rx's providers page; 10Rx's FAQ.

S4PASSThe FAQ explicitly states that compounded drugs themselves are not FDA-approved products and distinguishes them from standardized manufactured drugs.Source: 10Rx's FAQ.

S5FAILThe FAQ says pharmacy certificates of analysis and third-party testing are available upon request, but it does not publish a reachable certificate or lot document.Source: 10Rx's FAQ.

S6PASSThe terms list 9710 Kepler Mcveyv Ct., Spring, Texas 77379 for the business, separately from the clinical provider’s Kentucky address.Source: 10Rx's terms and conditions.

S7PASSSemaglutide is advertised at $99.67 a month on a quarterly plan billed $299 upfront. Tirzepatide is $149.67 a month with $449 billed upfront. These are prepaid quarterly equivalents, not monthly billing.Source: 10Rx's semaglutide injection product page; 10Rx's tirzepatide injection product page.

S8PASSNo FDA warning letter names 10Rx or 10Rx Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide with B12, tirzepatide, sermorelin, NAD+.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+

Visit 10Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.